Chokkalingam A. Risk of total non-hepatic cancer following treatment for HCV infection with direct-acting antiviral agents. PS-155.
Betere uitkomsten COVID-19 dankzij therapeutische antistolling
sep 2021 | Benigne hematologie, Pneumonie, Virale infecties